Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells

Gabriella Bergamini, Cristina Cigana, Claudio Sorio, Marco Della Peruta, Alfonso Pompella, Alessandro Corti, Francxois A. Huaux, Teresinha Leal, Baroukh M. Assael, Paola Melotti

Research output: Contribution to journalArticle

Abstract

Anti-inflammatory properties of azithromycin (AZM) have been proposed as possible mechanisms of clinical beneficial effects in patients with cystic fibrosis (CF). Altered glutathione (GSH) transport in cystic fibrosis transmembrane regulator protein (CFTR)-deficient cells leads to the occurrence of oxidative stress that finally induces glutathione S-transferase (GST) activity. The present investigation was aimed to verify the effects of AZM on GST activity and expression in CF airway cells in vitro and in vivo. AZM exposure significantly decreased GSTT1 and GSTM1 mRNA and protein expression in IB3-1, restoring the levels to those observed in non-CFC38 cells, which also express lower levels ofg-glutamyltransferase (GGT) activity than IB3-1. In another CF cell line, 2CFSMEo-, AZM produced 45% reduction in GSTT1 and GSTM1 mRNA levels. AZM reduced GST activity by approximately 25% and 40% in IB3-1 and 2CFSMEo- cells, respectively. GSTP1 was similarly expressed in all CF and non-CF cells and was unaffected by AZM. The anti-inflammatory cytokine IL-10 down-modulated GST activity at similar levels, supporting a link between GST inhibition and anti-inflammatory properties of AZM. In bronchoalveolar lavage fluid of CF mice homozygous for the F508 del mutation, GSTM1 protein levels were undetectable after AZM treatment. The association between increased GST expression and activity, together with its reversal by AZM treatment in vitro and in vivo, suggest novel antioxidant properties for this drug. The issue whether decreased GST activity may directly concur to anti-inflammatory properties of AZM or is rather a marker of the oxidative status of CF cells will require additional studies.

Original languageEnglish
Pages (from-to)199-206
Number of pages8
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume41
Issue number2
DOIs
Publication statusPublished - Aug 1 2009

Fingerprint

Azithromycin
Glutathione Transferase
Cystic Fibrosis
Anti-Inflammatory Agents
Glutathione
Messenger RNA
Proteins
Oxidative stress
Bronchoalveolar Lavage Fluid
Interleukin-10
Oxidative Stress
Fibrosis
Antioxidants
Cells
Association reactions
Cytokines
Cell Line
Mutation

Keywords

  • γ-glutamyltransferase
  • Azithromycin
  • Cystic fibrosis
  • Glutathione S-transferases
  • Inflammation

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells. / Bergamini, Gabriella; Cigana, Cristina; Sorio, Claudio; Della Peruta, Marco; Pompella, Alfonso; Corti, Alessandro; Huaux, Francxois A.; Leal, Teresinha; Assael, Baroukh M.; Melotti, Paola.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 41, No. 2, 01.08.2009, p. 199-206.

Research output: Contribution to journalArticle

Bergamini, G, Cigana, C, Sorio, C, Della Peruta, M, Pompella, A, Corti, A, Huaux, FA, Leal, T, Assael, BM & Melotti, P 2009, 'Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells', American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 2, pp. 199-206. https://doi.org/10.1165/rcmb.2008-0013OC
Bergamini, Gabriella ; Cigana, Cristina ; Sorio, Claudio ; Della Peruta, Marco ; Pompella, Alfonso ; Corti, Alessandro ; Huaux, Francxois A. ; Leal, Teresinha ; Assael, Baroukh M. ; Melotti, Paola. / Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells. In: American Journal of Respiratory Cell and Molecular Biology. 2009 ; Vol. 41, No. 2. pp. 199-206.
@article{7f73a91af014480bbfcd15fc913bf853,
title = "Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells",
abstract = "Anti-inflammatory properties of azithromycin (AZM) have been proposed as possible mechanisms of clinical beneficial effects in patients with cystic fibrosis (CF). Altered glutathione (GSH) transport in cystic fibrosis transmembrane regulator protein (CFTR)-deficient cells leads to the occurrence of oxidative stress that finally induces glutathione S-transferase (GST) activity. The present investigation was aimed to verify the effects of AZM on GST activity and expression in CF airway cells in vitro and in vivo. AZM exposure significantly decreased GSTT1 and GSTM1 mRNA and protein expression in IB3-1, restoring the levels to those observed in non-CFC38 cells, which also express lower levels ofg-glutamyltransferase (GGT) activity than IB3-1. In another CF cell line, 2CFSMEo-, AZM produced 45{\%} reduction in GSTT1 and GSTM1 mRNA levels. AZM reduced GST activity by approximately 25{\%} and 40{\%} in IB3-1 and 2CFSMEo- cells, respectively. GSTP1 was similarly expressed in all CF and non-CF cells and was unaffected by AZM. The anti-inflammatory cytokine IL-10 down-modulated GST activity at similar levels, supporting a link between GST inhibition and anti-inflammatory properties of AZM. In bronchoalveolar lavage fluid of CF mice homozygous for the F508 del mutation, GSTM1 protein levels were undetectable after AZM treatment. The association between increased GST expression and activity, together with its reversal by AZM treatment in vitro and in vivo, suggest novel antioxidant properties for this drug. The issue whether decreased GST activity may directly concur to anti-inflammatory properties of AZM or is rather a marker of the oxidative status of CF cells will require additional studies.",
keywords = "γ-glutamyltransferase, Azithromycin, Cystic fibrosis, Glutathione S-transferases, Inflammation",
author = "Gabriella Bergamini and Cristina Cigana and Claudio Sorio and {Della Peruta}, Marco and Alfonso Pompella and Alessandro Corti and Huaux, {Francxois A.} and Teresinha Leal and Assael, {Baroukh M.} and Paola Melotti",
year = "2009",
month = "8",
day = "1",
doi = "10.1165/rcmb.2008-0013OC",
language = "English",
volume = "41",
pages = "199--206",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells

AU - Bergamini, Gabriella

AU - Cigana, Cristina

AU - Sorio, Claudio

AU - Della Peruta, Marco

AU - Pompella, Alfonso

AU - Corti, Alessandro

AU - Huaux, Francxois A.

AU - Leal, Teresinha

AU - Assael, Baroukh M.

AU - Melotti, Paola

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Anti-inflammatory properties of azithromycin (AZM) have been proposed as possible mechanisms of clinical beneficial effects in patients with cystic fibrosis (CF). Altered glutathione (GSH) transport in cystic fibrosis transmembrane regulator protein (CFTR)-deficient cells leads to the occurrence of oxidative stress that finally induces glutathione S-transferase (GST) activity. The present investigation was aimed to verify the effects of AZM on GST activity and expression in CF airway cells in vitro and in vivo. AZM exposure significantly decreased GSTT1 and GSTM1 mRNA and protein expression in IB3-1, restoring the levels to those observed in non-CFC38 cells, which also express lower levels ofg-glutamyltransferase (GGT) activity than IB3-1. In another CF cell line, 2CFSMEo-, AZM produced 45% reduction in GSTT1 and GSTM1 mRNA levels. AZM reduced GST activity by approximately 25% and 40% in IB3-1 and 2CFSMEo- cells, respectively. GSTP1 was similarly expressed in all CF and non-CF cells and was unaffected by AZM. The anti-inflammatory cytokine IL-10 down-modulated GST activity at similar levels, supporting a link between GST inhibition and anti-inflammatory properties of AZM. In bronchoalveolar lavage fluid of CF mice homozygous for the F508 del mutation, GSTM1 protein levels were undetectable after AZM treatment. The association between increased GST expression and activity, together with its reversal by AZM treatment in vitro and in vivo, suggest novel antioxidant properties for this drug. The issue whether decreased GST activity may directly concur to anti-inflammatory properties of AZM or is rather a marker of the oxidative status of CF cells will require additional studies.

AB - Anti-inflammatory properties of azithromycin (AZM) have been proposed as possible mechanisms of clinical beneficial effects in patients with cystic fibrosis (CF). Altered glutathione (GSH) transport in cystic fibrosis transmembrane regulator protein (CFTR)-deficient cells leads to the occurrence of oxidative stress that finally induces glutathione S-transferase (GST) activity. The present investigation was aimed to verify the effects of AZM on GST activity and expression in CF airway cells in vitro and in vivo. AZM exposure significantly decreased GSTT1 and GSTM1 mRNA and protein expression in IB3-1, restoring the levels to those observed in non-CFC38 cells, which also express lower levels ofg-glutamyltransferase (GGT) activity than IB3-1. In another CF cell line, 2CFSMEo-, AZM produced 45% reduction in GSTT1 and GSTM1 mRNA levels. AZM reduced GST activity by approximately 25% and 40% in IB3-1 and 2CFSMEo- cells, respectively. GSTP1 was similarly expressed in all CF and non-CF cells and was unaffected by AZM. The anti-inflammatory cytokine IL-10 down-modulated GST activity at similar levels, supporting a link between GST inhibition and anti-inflammatory properties of AZM. In bronchoalveolar lavage fluid of CF mice homozygous for the F508 del mutation, GSTM1 protein levels were undetectable after AZM treatment. The association between increased GST expression and activity, together with its reversal by AZM treatment in vitro and in vivo, suggest novel antioxidant properties for this drug. The issue whether decreased GST activity may directly concur to anti-inflammatory properties of AZM or is rather a marker of the oxidative status of CF cells will require additional studies.

KW - γ-glutamyltransferase

KW - Azithromycin

KW - Cystic fibrosis

KW - Glutathione S-transferases

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=67651155937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651155937&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2008-0013OC

DO - 10.1165/rcmb.2008-0013OC

M3 - Article

C2 - 19097986

AN - SCOPUS:67651155937

VL - 41

SP - 199

EP - 206

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 2

ER -